Duloxetine in the treatment of postpartum-onset and non-postpartum onset major depressive disorder.

Trial Profile

Duloxetine in the treatment of postpartum-onset and non-postpartum onset major depressive disorder.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2016

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder; Postnatal depression
  • Focus Therapeutic Use
  • Acronyms DuloxPPD
  • Most Recent Events

    • 09 Feb 2016 Status changed from completed to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Aug 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top